The cost of losing: The risks and rewards of weight loss drugs | NBC 7 San Diego
The rise of weight loss drugs like Ozempic and Wegovy has sparked a revolution in the medical field, but it’s not without its controversies. The Cost of Losing: The Risks and Rewards of the Weight Loss Drugs Boom, a new NBC 7 documentary presented by Catherine Garcia, dives deep into the explosive popularity of these medications, exploring both the life-changing benefits and the potentially dangerous side effects. With a blend of patient testimonials, expert interviews, and industry insights, the film provides a balanced perspective on the impact of GLP-1 agonists, a class of drugs once reserved for diabetes management but now widely prescribed for weight loss.
The film navigates the experiences of patients who have seen both life-changing benefits and devastating side effects from these drugs. Through interviews with medical experts, researchers, and patients, the documentary uncovers the science behind how these medications work while shedding light on the unknown long-term risks and their potentially dangerous side effects, including severe gastrointestinal issues and mood changes.
Beyond the medical implications, the documentary delves into the larger social and ethical questions surrounding these drugs. It examines the influence of pharmaceutical companies, the role of doctors in prescribing these medications, and the societal obsession with thinness that often drives people to seek rapid weight loss. The Cost of Losing looks at these medications not just in terms of health, but also in terms of the stigma and financial inequalities that come with them. It’s a comprehensive look at the true price of the weight loss drug boom and what it means for individuals and society as a whole.
✔ SUBSCRIBE TO NBC 7 SAN DIEGO: https://www.youtube.com/channel/UCUPU09hfdemclhLeO_ecgnA?sub_confirmation=1
Visit the NBC 7 channel for the latest news, weather, investigations, consumer news (NBC 7 Responds) and exclusive reports: http://on.nbc7.com/yGmZDaa
